Inactive Instrument
Synergy Pharmaceuticals Inc Stock Nasdaq
Stocks
US8716393082
Biotechnology & Medical Research
| 1 day | -52.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Leslie M. Magnus
CTO | Chief Tech/Sci/R&D Officer | - | 2014-12-31 |
Stephen Comiskey
PRN | Corporate Officer/Principal | - | 2010-07-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -52.00% | -62.59% | - | - | 0 | |
| +2.07% | +13.76% | +65.44% | +106.53% | 71.56B | |
| -1.35% | -2.52% | +33.67% | +62.77% | 54.43B | |
| -4.50% | -4.69% | +2.82% | +463.22% | 27.59B | |
| -1.44% | -1.96% | +45.88% | +5.66% | 23.91B | |
| -0.67% | +1.02% | -18.32% | -13.84% | 23.14B | |
| +0.47% | +1.95% | +39.73% | -19.61% | 18.65B | |
| +0.35% | +12.02% | +257.19% | +466.50% | 18.64B | |
| -1.14% | -3.71% | +19.81% | +611.64% | 16.01B | |
| +0.46% | -3.05% | +31.49% | +135.18% | 12.54B | |
| Average | -5.80% | +4.06% | +53.08% | +202.00% | 29.61B | |
| Weighted average by Cap. | -0.39% | +3.63% | +50.72% | +163.06% |
Employees
-
